BMS-986165
IM011-021
Phase 2 small_molecule completed
Quick answer
BMS-986165 for Systemic Lupus Erythematosus is a Phase 2 program (small_molecule) at Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb
- Indication
- Systemic Lupus Erythematosus
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed